Stay updated on S 055746 Dose Escalation in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the S 055746 Dose Escalation in AML/MDS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes a completed Phase 1 dose-escalation study of S 055746 for acute myeloid leukaemia and high- or very-high-risk myelodysplastic syndrome, with its design, eligibility criteria, locations, and measured outcomes. It also outlines how researchers may request individual participant data and related study documents.
    Difference
    47%
    Check dated 2026-11-09T13:21:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T12:57:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces an NIH transition notice stating that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T12:53:09.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier updated from v3.7.1 to v3.7.2 while the study record page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T13:36:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:41:40.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with minimal header/navigation elements (Home) and a revision note. The previously visible study record content is replaced by an access-blocked state.
    Difference
    17%
    Check dated 2026-09-21T22:05:43.000Z thumbnail image

Stay in the know with updates to S 055746 Dose Escalation in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.